Recent News

Contact Us for Your Free Consultation

The Challenge of Treating Recurrent Prostate Cancer

Michael J. Dattoli, Arvind B. Soni, Lauren Yanthis, Jone Fay, Gregory Lawrence; Long-term outcomes for patients with radiorecurrent prostate cancer treated with salvage combination IMRT and brachytherapy, American Society of Clinical Oncology (ASCO), Genitourinary Symposium, January 2024.

Read More »

Testosterone: Friend or Foe?

Testosterone: Friend or Foe? MICHAEL DATTOLI, MD & GINYA CARNAHAN, APR, CRPC Perhaps one of the most controversial subjects in the prostate cancer world is

Read More »

Complex New Guidelines

Complex New Guidelines From Multiple Organizations Confuses Men About Prostate Cancer Screening WASHINGTON, March 3 /PRNewswire-USNewswire/ — Members of America’s Prostate Cancer Organizations are concerned

Read More »

Tools for Fighting Prostate Cancer

Experience and knowledge are tools for fighting prostate cancer Published: Thursday, June 19, 2008 at 2:31 a.m. Regarding Sunday’s front-page article, “As prostate drug gets

Read More »

Dual Therapy

Dual therapy can control high-risk prostate cancer David Douglas Mon Aug 27, 2007 10:14pm EDT NEW YORK (Reuters Health) – High rates of tumor control

Read More »

Purging Prostate Cancer

The latest technology at Dattoli Cancer Center & Brachytherapy Research Institute By: Virginia ‘Ginya’ Carnahan, APR, CPRC Michael Dattoli, MD, and Richard Sorace, MD, PhD,

Read More »

Clinical Outcomes Reported at ASTRO

Sunday, October 17, 2004 Clinical Outcomes Reported at ASTRO Demonstrate Effectiveness of Palladium-103 Brachytherapy in Treatment of Aggressive Prostate Cancer BUFORD, Ga., Oct 17, 2002-

Read More »

Contact Us for Your Free Consultation

WHAT OUR PATIENTS SAY ABOUT US